Posted on September 29, 2009 by Albin Paul
To gain an understanding of the current state of pharmacovigilance in the industry, Life Science Leader spoke with Sujith Eramangalath, the senior analyst in medical imaging, healthcare IT, and life sciences IT at Frost & Sullivan; Drew Kilpatrick, Ph.D., director of global safety and pharmacovigilance at Kendle; John Loucks, VP of Oracle Health Sciences; Nayan Nanavati, M.S., M.T., VP and general manager, peri- and post-approval research and worldwide head of pharmacovigilance at PAREXEL; and Charles Saldarini, CEO of Sentrx.
The Original Article published at Life Science Leader http://tinyurl.com/yzbqubv
Filed under: clinical informatics, oracle | Tagged: Life Sciences IT, Oracle AERS, Oracle Health Sciences, Oracle HSGBU, pharmacovigilance, Relsys, Relsys Argus | 2 Comments »
Posted on September 22, 2009 by Albin Paul
unSAP the Lifescience Industry with Oracle’s Healthy Lead in Lifescience Vericals. According to the latest IDC Insight Report
In the Oracle vs. SAP life sciences battle, Oracle gains a healthy lead. read the full report at
Filed under: microarray | Tagged: bioinformatics, clinical informatics, CRM, ERP, HSGBU, Lifescience, oracle, Relsys, SAP | Leave a comment »